Last reviewed · How we verify

(+/-)-Oxamniquine — Competitive Intelligence Brief

(+/-)-Oxamniquine (OXAMNIQUINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anthelmintic. Area: Infectious Disease.

marketed Anthelmintic Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

(+/-)-Oxamniquine (OXAMNIQUINE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
(+/-)-Oxamniquine TARGET OXAMNIQUINE marketed Anthelmintic 1980-01-01
Egaten TRICLABENDAZOLE Novartis marketed Anthelmintic [EPC] Transthyretin 2019-01-01
Albenza ALBENDAZOLE Impax Labs Inc marketed Anthelmintic [EPC] 1996-01-01
PRAZIQUANTEL PRAZIQUANTEL marketed Anthelmintic [EPC] 1982-01-01
Vermox MEBENDAZOLE marketed Anthelmintic [EPC] Vascular endothelial growth factor receptor 2 1974-01-01
Bovizole THIABENDAZOLE marketed Anthelmintic Cytochrome P450 1A2 1967-01-01
Caricide DIETHYLCARBAMAZINE Pfizer marketed Anthelmintic Arachidonate 5-lipoxygenase 1950-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anthelmintic class)

  1. · 2 drugs in this class
  2. Swiss Tropical & Public Health Institute · 2 drugs in this class
  3. Merck KGaA, Darmstadt, Germany · 1 drug in this class
  4. Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). (+/-)-Oxamniquine — Competitive Intelligence Brief. https://druglandscape.com/ci/oxamniquine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: